Henan Scorsese Technology Development Co., Ltd. – Trademark Portfolio

Entity Type: 99

Henan Scorsese Technology Development Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include PROHUM. The owner is based in Changyuan County.

Mancun Industrial Zone

Changyuan County 453400 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PROHUM
PROHUM
Registered 2020

Trademark Classifications

Henan Scorsese Technology Development Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Henan Scorsese Technology Development Co., Ltd. have?

Henan Scorsese Technology Development Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Henan Scorsese Technology Development Co., Ltd. file in?

Henan Scorsese Technology Development Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Henan Scorsese Technology Development Co., Ltd.'s most well-known trademarks?

Henan Scorsese Technology Development Co., Ltd.'s registered trademark portfolio includes well-known marks such as PROHUM. These are among 1 currently registered trademark in the portfolio.

What is Henan Scorsese Technology Development Co., Ltd.'s trademark registration success rate?

Henan Scorsese Technology Development Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.